Biosyntia closes 1.5 million EUR round to launch world’s first bio-based vitamin B7
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
MINYM can be safely used by patients above 9 years of age.
The appointments will add to the well-diversified experience that currently exists on the PPL board.
The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics
The combined company will be able to better serve both our global and regional customers with local production
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Subscribe To Our Newsletter & Stay Updated